JAK2 and myeloproliferative neoplasm: The latter were reported to play an important role in JAK2-mutant MPN progression as ROS was seen to accumulate in the hematopoietic stem-cell compartment of JAK2V617F knock-in mice and was found increased in patients with JAK2V617F mutant MPN [36].